Alain Bindels
About
Alain Bindels is from Basel, Basel, Switzerland. Alain is currently Founder & CEO at Basel Investor Forum, located in Basel, Switzerland. Alain also works as Executive Coach at nextImpact, a job Alain has held since Sep 2024. Another title Alain currently holds is VC Partner at Clarma Capital. In Alain's previous role as a Managing Partner Europe at FifthRow – Consulting as Software, Alain worked in Basel, Switzerland until Jul 2024. Prior to joining FifthRow – Consulting as Software, Alain was a Innovation & Technology Leader at Roche and held the position of Innovation & Technology Leader at Basel, Switzerland. Prior to that, Alain was a Innovation task force Leader at Roche, based in Basel Area, Switzerland from Jan 2014 to Aug 2023. Alain started working as Head of Innovation Facilitation & Digitalization at Roche in Basel Area, Switzerland in Jan 2019. From Jan 2018 to Dec 2018, Alain was Digital Innovation Lab Director at Roche, based in Basel Area, Switzerland. Prior to that, Alain was a Vendor Alliance Leader at Roche, based in Basel Area, Switzerland from Jan 2015 to Dec 2017. Alain started working as Global CSR Narrative Leader - Project Leader at Roche in Basel, Switzerland in Mar 2011.
Alain Bindels's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Alain Bindels's current jobs
I founded the Basel Investor Forum with a vision to create a high-impact, cross-border investment platform that bridges capital and innovation. As Managing Director, I lead the strategic direction, partnerships, and execution of the Forum, held annually during Art Basel week and other major events and other locations. Key Responsibilities: 🔹 Set and drive the overall vision, mission, and strategy of the Forum 🔹 Lead content development, from thematic programming to speaker curation 🔹 Oversee global sponsorship acquisition, relationship management & partner success 🔹 Curate a high-caliber, invite-only community of family offices, VCs, private equity firms, and other investors 🔹 Spearhead brand positioning, digital communications, and go-to-market campaigns 🔹 Facilitate cross-border LP/GP matchmaking, reverse pitching, and co-investment sessions 🔹 Manage end-to-end event production, including VIP private dinners and closed-door investor circles Industries & Focus Areas: -HealthTech & DeepTech -Healthcare (Biotech, Medtech, Longevity, Diagnostics, Digital Health) -Deeptech (Quantum, Spacetech, Climate tech, Energy tech, Blockchain, Next-gen Manufacturing and Materials) -Generative AI & Advanced Technologies -Impact Investing & ESG -Cross-Border Venture & Family Office Strategy The Basel Investor Forum is more than an event—it's a growing platform dedicated to aligning capital with scalable solutions for global challenges.
Supporting leaders and executives to connect, energize and get ready to make their move to their next impact without losing valuable time. We do this by providing a holistic program that includes 3 key modules: Connect. Energize and Make Your Move.
🚀Investing in breakthrough life sciences & health tech startups ✅Evaluated $100M+ in startup funding for medtech & digital health ventures ✅Advised portfolio startups on fundraising, go-to-market & product strategy ✅Connected startups with investors & corporate partners for scaling opportunities CLARMA CAPITAL invests in exciting life sciences companies with products that have the potential to revolutionize the standard of care. With team members based in London, Switzerland, Dublin, and Central Europe, CLARMA CAPITAL primarily targets European companies pioneering innovations in medical devices, medicinal products, and diagnostics.
🚀Helping health tech startups & corporates drive digital transformation ✅Developed market-entry & growth strategies for 20+ health tech startups ✅Supported corporate innovation programs with AI & digital health solutions ✅Provided mentorship & strategic consulting for early-stage ventures
The digitalization of healthcare is necessary to provide access to personalized and connected care. Kickstart’s Health & Wellbeing Vertical, co-founded by Swiss Healthcare Startups in 2019, is focused on identifying innovative and sustainable digital health startups and scaleups which have a validated business model and the potential to disrupt and digitize the healthcare industry. The goal is to spot the right new products/services and technologies that will help reshape the areas of wellbeing and mental health, lifestyle and prevention, care coordination, chronic pain and health data.
Being part of Global Entrepreneurship Week Basel as a volunteer to organize the week https://www.gewbasel.ch
Alain Bindels's past jobs
Fifthrow is a corporate venture builder, delivering digital innovation with startup DNA. To date, Fifhrow has brought 120+ successful businesses to market, creating over $2 billion in new value. Fifthrow build new ventures that align with growth strategies, supporting existing business units or spinning out as separate entities. Simultaneously, we concentrate on revitalizing underperforming ventures. We handle everything from conception to scaling, ensuring that our clients' ventures are successful at every stage of development. What we do: ☑️ Venture Building (Product development, marketing & design) ☑️ Innovation Strategy Advisory ☑️ SaaS AI InnovationOps Platform (using generative AI) ☑️ Startup acceleration ☑️ Venture Investing and M&A Support Get in touch via https://innovate.u.plus/contact-us.
The R&D Academy is an exciting venture aimed at supporting our R&D community to become the best healthcare solutions developers of the future. Our vision is to co-create learning, focused on future capabilities, to enable the Roche scientific community to deliver on the Pharma Vision. It's great to be part of this team and incorporate state of the art technology and innovation programs along this journey. In my role I am leading the strategy and vision of technology for our learning platform and the technology trends in R&D. I will connect the internal and external innovation ecosystems and manage innovation programs for the R&D community.
- I have lead and set up an innovation task force at Roche called the OneRoche Innovation Management Community of Practice. This community of practice is implemented across Roche Pharma and Diagnostics business units, including R&D and the commercial organizaton incl. affiliates to support the business to innovate and integrate innovation methodologies and frameworks to solve business challenges - designing and implementing an E2E process for innovation management that supports venture building and intrapreneurship in the organization, and set up and provide coaching services to global projects across multiple business units - Providing a platform for colleagues to find innovation resources and to connect multiple innovation programs across the organization and connect with external ecosystem (startups/entrepreneurs/universities/patients/customers) -Working with different business units and leadership teams across Pharma and Diagnostics to change the Innovation mindset and culture and integrate innovation methodologies - Building a purpose build network across company to foster innovation and create new opportunities - Focus on customer centricity, new technologies, entrepreneurship, intrapreneurship, digital health, and precision medicine/personalized healthcare
Building Innovation & Entrepreneurship capabilities within the organization. Agile coaching/design of programs and leadership coaching. Setting up an Intrapreneurship program (incubator) to support and coach Digital Health business challenges and co-create with external ecosystem(startups/customers/experts). These programs support our company’s culture transformation and generate business impact on our Digital healthcare strategy
Leading and managing the newly established Innovation lab to support Digital transformation @ Roche. The Innovation Lab is the platform for co-creation, prototyping, inspiration and experiments to foster innovation across business functions. Connecting internal and external innovation to foster an innovation ecosystem.
Leading the Governance Alliance team for outsourcing activities for Roche. Overseeing multiple operational areas across the Vendor Alliance, including medical writing activities, Clinical Study Report Narratives, Safety Science support, Aggregate safety reporting and Compliance Analyst activities.Overseeing the budget,the contracts, the metrics and Key performance indicators of the Alliance.
- Leading a medical writing Governance Team for Clinical Study Report (CSR) Narrative writing for all early and late stage clinical studies conducted at Roche & Genentech. - Implemented two CSR Narrative writing teams in two global sites (China: Beijing/Shanghai and vendor in India: Chandigargh). - Leading outsourcing of the Narrative writing process to vendor in India. - Developed training and roll-out plan for all clinical study teams across company. - Resource planning and allocation of medical writing resources to clinical studies. - Process optimization and monitoring. Interacting with global clinical study teams and CRO's. - Stakeholder management between global product development departments for CSR Narrative writing process.
Department PDS (Product Development Safety) - Being part of the Integration office managing the integration of Genentech and Roche for PDS. - Working on the implementation of Integrated Safety Management processes (cross-functional projects) (e.g.SAE reporting, Comparative Benefit-Risk Analysis, CSR Narrative writing) - Optimizing and developing new Safety processes - Managing the integration of Genentech and Roche for Safety department after the merger with Roche (Integration Project Office) - Applying and rolling out a new Project Management toolset
Pharma Development (Basel, Switzerland). Project proposed by Jean-Jacques Garaud (Head of Roche Pharma Development) in collaboration with Business School ESC Dijon. Analysis how to stimulate innovation within Pharma Industry using Harvard Burke-Litwin model to analyze Roche’s Innovation Strategy
Control and review of standard operating procedures.
Cancer Center Amsterdam VUMC Thesis title: ”The effects of Adjuvants on Dendritic cells”